Cue Biopharma is trading at $27.65, down 9.1% today in a sharp reversal from its July 30 close of $30.40, despite a lack of fresh company-specific news.
- The move appears to be a standalone pullback in the stock rather than a reaction to broader market or biotech sector trends.
- No earnings reports or significant corporate developments have been released to account for the sudden price drop.
- The broader market and biotech sector remain positive to mixed today, highlighting the stock's divergent performance.